KELES Analysis
What is KELES?
KELES is a €250m venture capital fund focused on European growth stage digital health companies with demonstrated profitability and scaling inflection points. Led by former Sanofi Chief Strategy Officer and a digital health VC partner, the firm targets high-potential startups in R&D, diagnostics, and patient care. It operates from Paris, London, Brussels, and Luxembourg with a proven track record of founding and scaling over 100 companies.
Location
Paris, London, Brussels, Luxembourg, France
Employees
11-50
Founded
2023
Product Features & Capabilities
- €250m fund for growth stage digital health
- €8m–€30m ticket size
- Investment in techbio and digitised trials
- Investment in AI imaging and digital medtech
- Investment in acute and chronic patient care
Use Cases
Fund startups in new R&D models using digitised trials; Invest in AI-powered diagnostic imaging startups; Support patient care companies scaling in acute and chronic settings
Other Considerations
Led by former Sanofi Chief Strategy Officer; Proven track record of founding and scaling over 100 companies; Invests in European digital health with focus on R&D, diagnostics, and patient care; Operates from Paris, London, Brussels, and Luxembourg; €250m fund with €8m–€30m ticket size; Targets startups at scaling inflection point with demonstrated profitability
See something that needs updating? Suggest edits to this profile.